Ghana Health Service Logo

GHS AND BOEHRINGER INGELHEIM LAUNCH CRM PATIENT AFRICA PROGRAM TO TACKLE CHRONIC KIDNEY DISEASE

The Ghana Health Service and Boehringer Ingelheim (BI), in partnership with IQVIA, have launched the Cardiovascular, Renal and Metabolic (CRM) Patient Africa Program in Ghana to strengthen the prevention, early detection, and management of chronic kidney disease (CKD) and related conditions. Held under the theme "Advancing Sustainable Healthcare in Ghana through Innovation, Partnership, and Impact," the initiative targets underserved communities through existing GHS structures to address Ghana's 13.3 per cent adult CKD prevalence.

November 16, 2026
4 min read
By PR Unit (GHS)

The Ghana Health Service and Boehringer Ingelheim (BI), in partnership with IQVIA, have launched the Cardiovascular, Renal and Metabolic (CRM) Patient Africa Program in Ghana to strengthen the prevention, early detection, and management of chronic kidney disease (CKD) and related conditions. Held under the theme "Advancing Sustainable Healthcare in Ghana through Innovation, Partnership, and Impact," the initiative targets underserved communities through existing GHS structures to address Ghana's 13.3 per cent adult CKD prevalence.

Delivering the opening remarks on behalf of the Director-General, Dr Samuel Kaba Akoriyea, Dr. Franklin Asiedu-Bekoe, Director of the Public Health Division, emphasized that behind every CKD diagnosis is a person striving to remain productive, care for their family, and afford treatment. Noting that late presentation, uneven access to diagnostics, and fragmented follow-up remain major challenges, Dr. Asiedu-Bekoe stressed the need to align the program with ongoing national health reforms specifically the rollout of Free Primary Health Care, the National Health Insurance Scheme (NHIS), and the Ghana Medical Trust Fund (MahamaCares) to ensure financial protection and prevention advance together.

Dr. Asiedu-Bekoe further outlined five key expectations for the partnership: stronger prevention and public understanding, enhanced frontline healthcare worker capacity with the necessary diagnostic tools and supervision, clearer and more reliable referral pathways between facilities, greater attention to affordability and equitable access beyond major urban centers, and measurable results that demonstrate earlier assessment and improved patient follow-up. Ultimately, he noted that the program's impact should be judged by how much easier it becomes for at-risk individuals to be identified early, for diagnosed patients to receive appropriate care, and for families to sustain that care.

Providing an overview of Boehringer Ingelheim’s broader initiatives, Dr. James Kinniburgh, Director, More Health, noted that the launch marks a shared commitment to move from evidence and discussion toward sustained action for patients and communities. He explained that because cardiovascular, renal, and metabolic conditions are deeply interconnected, late detection of CKD often narrows the window to slow its progression. He continued that through CRM Patient Africa, BI aims to work alongside GHS and national partners across four essential areas: generating local evidence through the CRM RISE study, supporting earlier identification, strengthening healthcare worker capabilities, and developing sustainable approaches to care continuity.

Dr. Kinniburgh emphasized that the next phase must be shaped by Ghana’s priorities and embedded within existing health structures to connect screening and diagnosis with referral, treatment, and long-term follow-up. He added that Boehringer Ingelheim’s commitment extends beyond a single program, pointing to initiatives such as the Making More Health and Bridge for Billions Demo Day which connects local health entrepreneurs with regulators, investors, and development partners, alongside ongoing work in health-system strengthening and One Health to build sustainable, locally led impact.

Presenting an overview of the CRM Patient Africa Program, Mr. Pradyoth John of Boehringer Ingelheim explained that the long-term initiative is specifically designed to prevent the onset or progression of chronic kidney disease across Sub-Saharan Africa. Taking a holistic approach built on interconnected modules, the program integrates a Real-World Evidence observational study to assess patient needs and guide targeted action, evidence-based training and capability building for healthcare professionals, digital CKD risk tools for early detection, and access schemes to ensure essential medicines reach those in need.

Mr. John further highlighted that, in partnership with IQVIA, the initiative seeks to strengthen existing local healthcare systems by collaborating closely with the public sector and communities while building on established programs and infrastructure to expand access to quality care. He also mentioned that the program forms part of Boehringer Ingelheim’s broader global commitment to expand access to healthcare for 50 million people in underserved communities by 2030.

The launch of the CRM Patient Africa Program marks an important step in strengthening the prevention, early detection, and management of chronic kidney disease in Ghana. Through collaboration between the Ghana Health Service, Boehringer Ingelheim, and IQVIA, the initiative is expected to improve access to quality care, build healthcare capacity, and support better health outcomes for people at risk of or living with chronic kidney disease across the country.

Share this article

Spread the knowledge with your network

Comments

No comments yet. Be the first to comment!

No comments yet

Start the conversation by posting the first comment above.